Section Arrow
SLP.NASDAQ
- Simulations Plus
Quotes are at least 15-min delayed:2025/11/21 01:14 EST
Regular Hours
Last
 16.68
+0.36 (+2.21%)
Day High 
16.8 
Prev. Close
16.32 
1-M High
18.95 
Volume 
431.76K 
Bid
16.69
Ask
16.7
Day Low
16.26 
Open
16.59 
1-M Low
15.165 
Market Cap 
328.47M 
Currency USD 
P/E 35.94 
%Yield 0.36 
10-SMA 17.11 
20-SMA 17.31 
50-SMA 16.21 
52-W High 37.665 
52-W Low 12.39 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-3.15/0.99
Enterprise Value
329.01M
Balance Sheet
Book Value Per Share
6.15
Cash Flow
Cash Flow Yield
0.04
Income Statement
Total Revenue
70.01M
Operating Revenue Per Share
2.96
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
MNDRMobile-health Network Solutions3.04+1.38+83.13%-- 
TDOCTeladoc Health6.76-0.29-4.11%-- 
GEHCGE HealthCare Technologies74.75+2.44+3.37%14.88PE
TEMTempus AI Inc.65.69-3.4-4.92%36.4PE
EVHEvolent Health3.69+0.15+4.24%-- 
Quotes are at least 15-min delayed:2025/11/21 01:14 EST
Industry overview quotes are at least 15 minutes delayed
Business Description
Simulations Plus Inc is engaged in the software industry. It includes two segments. It develops and produces software for use in pharmaceutical research and education, and provides consulting and contract research services to the pharmaceutical industry. The company's operating segments include Software and services. The company offers software products for pharmaceutical research such as ADMET (Absorption, Distribution, Metabolism, Excretion, and Toxicity). It generates maximum revenue from the software segment. Maximum revenue is earned from USA following EMEA and Asia Pacific.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.